Literature DB >> 33748274

Correlation between TNF-α -308 and +489 Gene Polymorphism and Acute Exacerbation of Chronic Obstructive Pulmonary Diseases.

Suyun Yu1, Min Xue1, Zhijun Yan1, Bin Song2, Haiping Hong3, Xiwen Gao1.   

Abstract

Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is becoming a common respiratory disease, leading to increased morbidity and mortality worldwide. Tumor necrosis factor-alpha (TNF-α) is a powerful proinflammatory cytokine involved in the pathogenesis of AECOPD. Therefore, we proposed a close correlation between the TNF-α polymorphism [-308G/A (rs1800629), +489G/A (rs1800610)] and the disease progress of patients with AECOPD. Comparison of the TNF-α genotypes between the 198 AECOPD diagnosed patients groups and 195 healthy peoples suggested their significant differences of the three genotypes (AA, GA, GG) distribution for TNF-α -308 (P < 0.05), but no differences of that for TNF-α +489. We found that patients with TNF-α -308 GA/AA genotypes showed smaller adjacent arterial diameter, thicker bronchial wall, higher bronchial artery ratio, higher bronchial wall grading, and higher frequency of acute exacerbations than those with TNF-α -308 GG genotype. Patients with TNF-α +489 GA/AA genotypes showed the same AECOPD properties as patients with TNF-α -308 except for the high frequency of acute exacerbations. Further experiment showed that the TNF-α -308 and+489 gene polymorphisms could affect the expression level of TNF-α in macrophages, suggesting the involvement of the macrophage population in disease regulation of AECOPD patients with TNF-α -308G/A and+489G/A genotype heterogeneity. In conclusion, the TNF-α -308 G/A genotype was related to AECOPD susceptibility and progress, while the TNF-α +489G/A genotype was related to AECOPD progress, but not AECOPD susceptibility.
Copyright © 2021 Suyun Yu et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33748274      PMCID: PMC7943264          DOI: 10.1155/2021/6661281

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  35 in total

1.  Chronic obstructive pulmonary disease phenotypes: the future of COPD.

Authors:  MeiLan K Han; Alvar Agusti; Peter M Calverley; Bartolome R Celli; Gerard Criner; Jeffrey L Curtis; Leonardo M Fabbri; Jonathan G Goldin; Paul W Jones; William Macnee; Barry J Make; Klaus F Rabe; Stephen I Rennard; Frank C Sciurba; Edwin K Silverman; Jørgen Vestbo; George R Washko; Emiel F M Wouters; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2010-06-03       Impact factor: 21.405

2.  Tumor necrosis factor gene complex in COPD and disseminated bronchiectasis.

Authors:  C Patuzzo; L S Gilè; M Zorzetto; E Trabetti; G Malerba; P F Pignatti; M Luisetti
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

3.  Alterations of plasma inflammatory biomarkers in the healthy and chronic obstructive pulmonary disease patients with or without acute exacerbation.

Authors:  Hong Chen; Yaoli Wang; Chunxue Bai; Xiangdong Wang
Journal:  J Proteomics       Date:  2012-02-10       Impact factor: 4.044

4.  Polymorphisms of TNFalpha, IL1beta, and IL1RN genes in chronic obstructive pulmonary disease.

Authors:  Ahmed E Hegab; Tohru Sakamoto; Wataru Saitoh; Akihiro Nomura; Yukio Ishii; Yuko Morishima; Takashi Iizuka; Takumi Kiwamoto; Yosuke Matsuno; Hosam H Massoud; Hosny M Massoud; Khalid M Hassanein; Kiyohisa Sekizawa
Journal:  Biochem Biophys Res Commun       Date:  2005-04-22       Impact factor: 3.575

5.  Inflammatory Breast Cancer Promotes Development of M2 Tumor-Associated Macrophages and Cancer Mesenchymal Cells through a Complex Chemokine Network.

Authors:  Amanda Valeta-Magara; Abhilash Gadi; Viviana Volta; Beth Walters; Rezina Arju; Shah Giashuddin; Hua Zhong; Robert J Schneider
Journal:  Cancer Res       Date:  2019-05-01       Impact factor: 12.701

6.  Susceptibility to exacerbation in chronic obstructive pulmonary disease.

Authors:  John R Hurst; Jørgen Vestbo; Antonio Anzueto; Nicholas Locantore; Hana Müllerova; Ruth Tal-Singer; Bruce Miller; David A Lomas; Alvar Agusti; William Macnee; Peter Calverley; Stephen Rennard; Emiel F M Wouters; Jadwiga A Wedzicha
Journal:  N Engl J Med       Date:  2010-09-16       Impact factor: 91.245

Review 7.  Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research.

Authors:  Joanna Smolonska; Cisca Wijmenga; Dirkje S Postma; H Marike Boezen
Journal:  Am J Respir Crit Care Med       Date:  2009-07-16       Impact factor: 21.405

8.  Association of TNF-alpha gene polymorphisms with systemic lupus erythematosus in Taiwanese patients.

Authors:  Y-J Lin; R-H Chen; L Wan; Jj-C Sheu; C-M Huang; C-W Lin; S-Y Chen; C-H Lai; Y-C Lan; K-C Hsueh; C-H Tsai; T-H Lin; Y-M Huang; K Chao; D-Y Chen; F-J Tsai
Journal:  Lupus       Date:  2009-10       Impact factor: 2.911

Review 9.  Molecular mechanisms that influence the macrophage m1-m2 polarization balance.

Authors:  Nan Wang; Hongwei Liang; Ke Zen
Journal:  Front Immunol       Date:  2014-11-28       Impact factor: 7.561

10.  Changes in Th1/Th2-producing cytokines during acute exacerbation chronic obstructive pulmonary disease.

Authors:  Bing Wei; Chun Sheng Li
Journal:  J Int Med Res       Date:  2018-06-27       Impact factor: 1.671

View more
  3 in total

1.  Environmental and Genetic Factors in the Pathogenesis of COPD in the Road-Working Population.

Authors:  Yumin Zhou; Man Wang; Weiyan Yang; Jianjun Li; Jialin Li; Yueying Hu; Wei Wang; Chunli Che; Hong Qi
Journal:  Dis Markers       Date:  2021-04-29       Impact factor: 3.434

Review 2.  Association Between TNF-α-308, +489, -238 Polymorphism, and COPD Susceptibility: An Updated Meta-Analysis and Trial Sequential Analysis.

Authors:  Zhiyu Xia; Yufei Wang; Fu Liu; Hongxin Shu; Peng Huang
Journal:  Front Genet       Date:  2022-01-21       Impact factor: 4.599

3.  SMAD4 rs10502913 is Significantly Associated with Chronic Obstructive Pulmonary Disease in a Chinese Han Population: A Case-Control Study.

Authors:  Zhifei Hou; Zhihui Yuan; Hao Wang; Kang Chang; Yong Gao
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-07-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.